美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MetaVia Inc

1.32

+0.02001.54%

盤後：1.330.0148+1.12%19:51 EDT

成交量：5.43萬

成交額：7.24萬

市值：423.48萬

市盈率：-0.12

高：1.36

開：1.30

低：1.30

收：1.30

52周最高：23.10

52周最低：1.22

股本：320.82萬

流通股本：228.84萬

量比：0.27

換手率：2.37%

股息：- -

股息率：- -

每股收益(TTM):-11.3639

每股收益(LYR):-39.1268

淨資產收益率：-168.18%

總資產收益率：-58.41%

市淨率：0.67

市盈率(LYR):-0.03

資料載入中...

總覽公司新聞資訊公告

BUZZ-MetaVia 因獲監管機構批准開始早期肥胖症試驗而上漲

MetaVia獲IRB批准推進DA-1726高劑量一期試驗 GLP-1/胰高血糖素雙激動劑展現最佳減重與血糖控制潛力

Metavia Inc.盤中異動下午盤急速上漲5.30%

Metavia Inc.盤中異動股價大漲5.30%報1.59美元

BUZZ--美國股票走勢-Opus Genetics、MetaVia、Enbridge

BUZZ-MetaVia 公司肥胖症藥物獲得全球專利保護後股價上漲

MetaVia構築DA-1726全球專利保護網，新型肥胖代謝療法獨佔權延至2041年

MetaVia Inc與Syntekabio合作AI建模獲突破進展確認Vanoglipel關鍵治療靶點

MetaVia公布Da-1726代謝疾病一期B臨床試驗積極結果——顯著血糖控制、直接肝臟效應突出、減重效果強勁且安全性良好

Metavia Inc.盤中異動早盤急速下挫5.21%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/MTVA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":1.32,"timestamp":1774555200000,"preClose":1.3,"halted":0,"volume":54346,"hourTrading":{"tag":"盘后","latestPrice":1.3348,"preClose":1.32,"latestTime":"19:51 EDT","volume":1466,"amount":1951.0894312,"timestamp":1774569103317,"change":0.0148,"changeRate":0.011212,"amplitude":0.022727},"delay":0,"changeRate":0.015384615384615398,"floatShares":2288400,"shares":3208200,"eps":-11.363935,"marketStatus":"盤後交易","change":0.02,"latestTime":"03-26 19:54:39 EDT","open":1.3,"high":1.36,"low":1.3,"amount":72433.6313656,"amplitude":0.046154,"askPrice":1.36,"askSize":999,"bidPrice":1.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-11.363935,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.32,"preClose":1.3,"latestTime":"09:29 EDT","volume":1352,"amount":1765.4801320000001,"timestamp":1774531760362,"change":0.02,"changeRate":0.015385,"amplitude":0.038462},"postHourTrading":{"tag":"盘后","latestPrice":1.3348,"preClose":1.32,"latestTime":"19:51 EDT","volume":1466,"amount":1951.0894312,"timestamp":1774569103317,"change":0.0148,"changeRate":0.011212,"amplitude":0.022727},"volumeRatio":0.270956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":2288400,"roa":"-58.41%","roe":"-168.18%","lyrEps":-39.126846,"volumeRatio":0.270956,"shares":3208200,"dividePrice":0,"high":1.36,"amplitude":0.046154,"preClose":1.3,"low":1.3,"week52Low":1.2167,"pbRate":"0.67","week52High":23.1,"institutionHeld":0,"latestPrice":1.32,"committee":-0.818016,"eps":-11.363935,"divideRate":0,"volume":54346,"delay":0,"ttmEps":-11.363935,"open":1.3,"prevYearClose":8.42,"prevWeekClose":1.41,"prevMonthClose":1.51,"prevQuarterClose":8.42,"fiveDayClose":1.48,"twentyDayClose":1.59,"sixtyDayClose":9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-2.06,"defaultRemindTime":1774512000000,"name":null,"time":"盤前","dateTimestamp":1774497600000,"actualEps":null},{"market":"US","date":"2025-12-05","symbol":"MTVA","defaultRemindTime":1764945000000,"type":"split","dateTimestamp":1764910800000,"forFactor":11,"toFactor":1,"ratio":11},{"market":"US","date":"2025-11-06","symbol":"MTVA","fiscalQuarterEnding":"2025/09","expectedEps":-0.26,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-08-07","symbol":"MTVA","fiscalQuarterEnding":"2025/06","expectedEps":-0.32,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-05-14","symbol":"MTVA","fiscalQuarterEnding":"2025/03","expectedEps":-0.57,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2026-03-25","current":-0.116157,"percent":0.926606,"low":-1.962939,"twenty":-1.120098,"median":-0.562464,"eighty":-0.435504,"high":-0.203888,"avg":-0.699742,"sd":0.360738,"marketCap":4202760},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270},{"date":"2025-04-25","current":-0.266622,"twenty":-0.631917,"median":-0.512617,"eighty":-0.463425,"marketCap":7356638},{"date":"2025-05-02","current":-0.239019,"twenty":-0.626947,"median":-0.506404,"eighty":-0.454331,"marketCap":6595010},{"date":"2025-05-09","current":-0.222708,"twenty":-0.618869,"median":-0.49874,"eighty":-0.452346,"marketCap":6144956},{"date":"2025-05-16","current":-0.238257,"twenty":-0.615141,"median":-0.497083,"eighty":-0.429105,"marketCap":5848960},{"date":"2025-05-23","current":-0.285534,"twenty":-0.611413,"median":-0.49458,"eighty":-0.263184,"marketCap":7009578},{"date":"2025-05-30","current":-0.543676,"twenty":-0.612655,"median":-0.49689,"eighty":-0.271352,"marketCap":13346706},{"date":"2025-06-06","current":-0.549972,"twenty":-0.608927,"median":-0.497673,"eighty":-0.281282,"marketCap":13501264},{"date":"2025-06-13","current":-0.597709,"twenty":-0.608927,"median":-0.503297,"eighty":-0.294785,"marketCap":14673160},{"date":"2025-06-20","current":-0.557862,"twenty":-0.607995,"median":-0.509511,"eighty":-0.332562,"marketCap":13694949},{"date":"2025-06-27","current":-0.542591,"twenty":-0.603956,"median":-0.515396,"eighty":-0.428478,"marketCap":13320078},{"date":"2025-07-03","current":-0.516978,"twenty":-0.602714,"median":-0.515103,"eighty":-0.429732,"marketCap":12691292},{"date":"2025-07-11","current":-0.572913,"twenty":-0.599701,"median":-0.516978,"eighty":-0.432869,"marketCap":14064436},{"date":"2025-07-18","current":-0.535431,"twenty":-0.597709,"median":-0.518414,"eighty":-0.439456,"marketCap":13144307},{"date":"2025-07-25","current":-0.587857,"twenty":-0.5965,"median":-0.521601,"eighty":-0.450482,"marketCap":14431313},{"date":"2025-08-01","current":-0.482926,"twenty":-0.587857,"median":-0.520838,"eighty":-0.453589,"marketCap":11855342},{"date":"2025-08-08","current":-0.674088,"twenty":-0.587857,"median":-0.518654,"eighty":-0.453589,"marketCap":12464564},{"date":"2025-08-15","current":-0.837521,"twenty":-0.602714,"median":-0.525504,"eighty":-0.453589,"marketCap":15486597},{"date":"2025-08-22","current":-0.836212,"twenty":-0.615141,"median":-0.534692,"eighty":-0.453589,"marketCap":15462399},{"date":"2025-08-29","current":-0.846681,"twenty":-0.624461,"median":-0.53558,"eighty":-0.454826,"marketCap":15655982},{"date":"2025-09-05","current":-0.898895,"twenty":-0.643102,"median":-0.537471,"eighty":-0.457336,"marketCap":16621475},{"date":"2025-09-12","current":-0.894708,"twenty":-0.675347,"median":-0.537746,"eighty":-0.459434,"marketCap":16544042},{"date":"2025-09-19","current":-1.200403,"twenty":-0.704615,"median":-0.540578,"eighty":-0.459802,"marketCap":22196650},{"date":"2025-09-26","current":-1.308626,"twenty":-0.720771,"median":-0.542033,"eighty":-0.464632,"marketCap":24197809},{"date":"2025-10-03","current":-1.285464,"twenty":-0.777314,"median":-0.543184,"eighty":-0.467223,"marketCap":23769507},{"date":"2025-10-10","current":-1.347885,"twenty":-0.814044,"median":-0.546792,"eighty":-0.468812,"marketCap":24923743},{"date":"2025-10-17","current":-1.360971,"twenty":-0.829721,"median":-0.548697,"eighty":-0.471608,"marketCap":25165721},{"date":"2025-10-24","current":-1.257721,"twenty":-0.836474,"median":-0.551486,"eighty":-0.475169,"marketCap":23256514},{"date":"2025-10-31","current":-1.275649,"twenty":-0.839353,"median":-0.556987,"eighty":-0.478202,"marketCap":23588024},{"date":"2025-11-07","current":-1.112332,"twenty":-0.856339,"median":-0.562326,"eighty":-0.479691,"marketCap":20568137},{"date":"2025-11-14","current":-0.985555,"twenty":-0.895545,"median":-0.562464,"eighty":-0.481224,"marketCap":15981760},{"date":"2025-11-21","current":-0.990035,"twenty":-0.925649,"median":-0.572913,"eighty":-0.482587,"marketCap":16054404},{"date":"2025-11-28","current":-1.16176,"twenty":-1.03994,"median":-0.573323,"eighty":-0.482894,"marketCap":18839105},{"date":"2025-12-05","current":-0.993021,"twenty":-1.048481,"median":-0.575956,"eighty":-0.483005,"marketCap":16102829},{"date":"2025-12-12","current":-1.162032,"twenty":-1.114901,"median":-0.581053,"eighty":-0.483057,"marketCap":18843504},{"date":"2025-12-19","current":-1.126736,"twenty":-1.121412,"median":-0.584073,"eighty":-0.483629,"marketCap":18271155},{"date":"2025-12-26","current":-1.324933,"twenty":-1.135751,"median":-0.58567,"eighty":-0.484268,"marketCap":21485117},{"date":"2026-01-02","current":-1.143026,"twenty":-1.158344,"median":-0.587519,"eighty":-0.484763,"marketCap":18535316},{"date":"2026-01-09","current":-1.138004,"twenty":-1.161978,"median":-0.597709,"eighty":-0.485344,"marketCap":18453866},{"date":"2026-01-16","current":-0.447979,"twenty":-1.16176,"median":-0.601208,"eighty":-0.485344,"marketCap":7264435},{"date":"2026-01-23","current":-0.551981,"twenty":-1.16176,"median":-0.598705,"eighty":-0.485958,"marketCap":8950917},{"date":"2026-01-30","current":-0.466908,"twenty":-1.144681,"median":-0.593528,"eighty":-0.48519,"marketCap":7571385},{"date":"2026-02-06","current":-0.342268,"twenty":-1.143026,"median":-0.58718,"eighty":-0.483057,"marketCap":5550210},{"date":"2026-02-13","current":-0.328419,"twenty":-1.140855,"median":-0.584073,"eighty":-0.480757,"marketCap":5325635},{"date":"2026-02-20","current":-0.308634,"twenty":-1.138574,"median":-0.583444,"eighty":-0.475169,"marketCap":5004813},{"date":"2026-02-27","current":-0.31457,"twenty":-1.130076,"median":-0.57751,"eighty":-0.466694,"marketCap":5101060},{"date":"2026-03-06","current":-0.31457,"twenty":-1.127008,"median":-0.573733,"eighty":-0.459434,"marketCap":5101060},{"date":"2026-03-13","current":-0.318526,"twenty":-1.122978,"median":-0.572913,"eighty":-0.453589,"marketCap":5165224},{"date":"2026-03-20","current":-0.292807,"twenty":-1.121203,"median":-0.56645,"eighty":-0.449981,"marketCap":4748156},{"date":"2026-03-25","current":-0.259174,"twenty":-1.120098,"median":-0.562464,"eighty":-0.435504,"marketCap":4202760}],"updateTime":1774569279984},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620025544","title":"BUZZ-MetaVia 因獲監管機構批准開始早期肥胖症試驗而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2620025544","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620025544?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 20:42","pubTimestamp":1773837720,"startTime":"0","endTime":"0","summary":"** 迈阿密临床药理学机构审查委员会的批准允许该公司开始招收早期试验下一部分的参与者，该试验旨在通过两种不同的滴定方案评估更高的药物剂量。** MetaVia公司表示，早期试验的第三部分将招募40名健康的肥胖症成人患者。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4S406146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"1187742668","title":"MetaVia獲IRB批准推進DA-1726高劑量一期試驗 GLP-1/胰高血糖素雙激動劑展現最佳減重與血糖控制潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1187742668","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187742668?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 20:03","pubTimestamp":1773835407,"startTime":"0","endTime":"0","summary":"MetaVia Inc宣布，其核心肥胖治疗项目DA-1726获得机构审查委员会批准，将开展更高剂量的第一阶段临床试验。DA-1726是一种GLP-1与胰高血糖素双受体激动剂，临床前数据显示其在减重和血糖控制方面具备同类最佳潜力。DA-1726通过同时激活GLP-1和胰高血糖素受体，模拟肠道激素的自然作用。MetaVia计划在本季度内启动高剂量组的一期临床试验，重点评估DA-1726在健康受试者中的安全性、耐受性及药代动力学特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2616036393","title":"Metavia Inc.盤中異動 下午盤急速上漲5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616036393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616036393?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 03:37","pubTimestamp":1772480262,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日03时37分，Metavia Inc.股票出现波动，股价快速上涨5.30%。截至发稿，该股报1.59美元/股，成交量4.7403万股，换手率1.43%，振幅5.30%。Metavia Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Metavia Inc.公司简介：MetaVia Inc是一家临床阶段的生物技术公司，专注于开发治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030303374297a7b44c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030303374297a7b44c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OXM","MTVA","BK4139","BK4202"],"gpt_icon":0},{"id":"2614461177","title":"Metavia Inc.盤中異動 股價大漲5.30%報1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614461177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614461177?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 23:04","pubTimestamp":1771945446,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日23时04分，Metavia Inc.股票出现异动，股价快速拉升5.30%。截至发稿，该股报1.59美元/股，成交量7123股，换手率0.21%，振幅2.07%。Metavia Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Metavia Inc.公司简介：MetaVia Inc是一家临床阶段的生物技术公司，专注于开发治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022423040697a6e1bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022423040697a6e1bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTVA","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2611689051","title":"BUZZ--美國股票走勢-Opus Genetics、MetaVia、Enbridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2611689051","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611689051?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 22:12","pubTimestamp":1770991924,"startTime":"0","endTime":"0","summary":"nL4N3Z90X1 ** Expedia Group Inc EXPE.O:BUZZ - 在预测 2026 年调整后核心利润率增长放缓后下跌。nL4N3Z912F ** Wendy's Co WEN.O:BUZZ - 在年度利润预测低于预期后下跌。nL4N3Z9141 ** Watts Water Technologies Inc WTS.N:BUZZ - 因数据中心需求强劲，Stifel 上调 Watts Water 目标价。nL4N3Z911S ** Instacart Inc CART.O:BUZZ - 因第一季度预测和第四季度业绩乐观而跳涨。nL6N3Z90RQ ** Opus Genetics Inc IRD.O:BUZZ - 在为视力治疗项目融资 2500 万美元后上涨。nL4N3Z90ZC ** Bio-Rad Laboratories Inc BIO.N:BUZZ - 因第四季度利润不及预期而下滑。nL4N3Z9184 ** MetaVia Inc MTVA.O:BUZZ - 因肥胖症药物获得全球专利保护而上涨。nL4N3Z919F ** Enbridge Inc ENB.N:BUZZ - 季度利润超过预期，股价上涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL4T3Z91AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDE","IRD","LU1861558580.USD","HL","ENB","LU1169589451.USD","CHRS","LU2237443978.SGD","LU0788109121.HKD","LU1104425308.USD","ROKU","LU1035773651.USD","PINS","BIO","MTVA","LU0345780950.USD","BK4539","EXPE","HWM","TPH","BK4114","RIVN","PRU.UK","HK0000914660.USD","DKNG","LU2543165471.USD","AAP","LU0154245756.USD","LU0345780521.USD","LU0266512127.USD","IMUX","LU2317271919.USD","AMKR","LU3187612489.SGD","TOST","ABNB","CART","LU0738911758.USD","RYAN","LU0456854461.SGD","BK4121","WTS","WEN","BK4608","LU0345780281.USD","FDX","DLTR","AU","LU1015430645.USD","NEM"],"gpt_icon":0},{"id":"2611150243","title":"BUZZ-MetaVia 公司肥胖症藥物獲得全球專利保護後股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2611150243","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611150243?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 21:55","pubTimestamp":1770990942,"startTime":"0","endTime":"0","summary":"BUZZ-MetaVia 公司肥胖症药物获得全球专利保护后股价上涨2月13日 - ** 药物开发商 MetaVia MTVA.O 股价盘前上涨 6% 至 1.76 美元** 该公司表示，它已为其实验性药物DA-1726获得了广泛的专利保护，该药物旨在帮助人们在美国和国际上减肥和改善血糖水平。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL4T3Z91A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"1148696413","title":"MetaVia構築DA-1726全球專利保護網，新型肥胖代謝療法獨佔權延至2041年","url":"https://stock-news.laohu8.com/highlight/detail?id=1148696413","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148696413?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 21:33","pubTimestamp":1770989628,"startTime":"0","endTime":"0","summary":"MetaVia公司已完成针对创新疗法DA-1726的全球专利布局，成功将这款新型肥胖与代谢疾病治疗方案的独家商业化权利锁定至2041年。该专利体系覆盖主要医药市场，为双靶点激动剂的商业化铺平道路。专利壁垒的建立不仅巩固了企业在代谢疾病领域的竞争优势，更意味着未来二十年患者有望获得突破性治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"1150245570","title":"MetaVia Inc與Syntekabio合作AI建模獲突破進展 確認Vanoglipel關鍵治療靶點","url":"https://stock-news.laohu8.com/highlight/detail?id=1150245570","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150245570?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 21:06","pubTimestamp":1770210383,"startTime":"0","endTime":"0","summary":"MetaVia Inc公布其与Syntekabio持续合作中人工智能建模研究的积极成果。最新数据证实，双方共同开发的糖尿病肾病治疗药物Vanoglipel已通过AI模型精准锁定关键治疗靶点。\n这项突破性进展标志着AI驱动药物研发模式在复杂疾病领域的应用迈出重要一步。通过深度学习算法分析海量生物医学数据，研究团队成功验证了Vanoglipel作用于肾脏纤维化与炎症通路的核心机制。\n合作双方表示，该成果将显著加速Vanoglipel的临床前开发进程。AI建模不仅缩短了传统靶点确认周期，更通过多维度模拟预测了化合物与靶点相互作用的特异性，为后续药物优化提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"1148649541","title":"MetaVia公布Da-1726代謝疾病一期B臨床試驗積極結果——顯著血糖控制、直接肝臟效應突出、減重效果強勁且安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1148649541","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148649541?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 21:30","pubTimestamp":1767619821,"startTime":"0","endTime":"0","summary":"MetaVia Inc宣布其针对代谢疾病的候选药物Da-1726在一期B期临床试验中取得具有统计学意义的积极数据。该试验结果显示，Da-1726不仅能有效调控血糖水平，还展现出对肝脏的直接作用机制。此外，受试者在接受治疗后出现显著的体重下降，同时药物整体安全性表现优异，未出现严重不良反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2583531690","title":"Metavia Inc.盤中異動 早盤急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583531690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583531690?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 23:41","pubTimestamp":1762962109,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时41分，Metavia Inc.股票出现异动，股价快速下跌5.21%。Metavia Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为6158.01%、521.51%、381.17%，振幅较大的相关个股有Leap Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为115.43%、47.96%、47.55%。Metavia Inc.公司简介：MetaVia Inc是一家临床阶段的生物技术公司，专注于开发治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112234149a49cc80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112234149a49cc80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OXM","MTVA","BK4139","BK4202"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}